证券时报·数据宝统计显示，聚杰微纤今日收盘价为29.33元，上涨1.28%，日换手率为8.60%，成交额为 3.34亿元，全天主力资金净流入454.26万元，近5日该股累计上涨19.37%，近5日资金合计净流入4459.69 万元。 据天眼查APP显示，江苏聚杰微纤科技集团股份有限公司成立于2000年05月26日，注册资本14920.5万 人民币。（数据宝） | 成交量 | 成交金 | 成交价 | 相对当日收 | | | | --- | --- | --- | --- | --- | --- | | （万 | 额（万 | 格 | 盘折溢价 | 买方营业部 | 卖方营业部 | | 股） | 元） | （元） | （%） | | | | 200.00 | 4634.00 | 23.17 | -21.00 | 国泰海通证券股份有限公司 上海长宁区江苏路证券营业 | 光大证券股份有限公司苏州 | | | | | | 部 | 文苑路证券营业部 | | | | | | 国泰海通证券股份有限公司 | 国泰海通证券股份有限公司 | | 98.41 | 2280.16 | 23.17 | -21.00 | 上海长宁区江苏路证券 ...

格隆汇12月8日丨聚杰微纤(300819.SZ)公布，公司于2025年12月8日收到控股股东聚杰投资《关于股份 减持计划完成的告知函》，聚杰投资于2025年12月8日以大宗交易方式累计减持公司股份2,984,100股， 占公司总股本的2%。 ...

江苏聚杰微纤科技集团股份有限公司 关于控股股东减持股份计划实施完毕 暨持股比例触及1%整数倍的公告 证券代码：300819 证券简称：聚杰微纤 公告编号：2025-042 控股股东苏州市聚杰投资有限公司保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏聚杰微纤科技集团股份有限公司（以下简称"公司"）于 2025 年11月13日在巨潮资讯网披露了《关于控股股东减持股份的预披露公告》 （公告编号：2025-041）。公司控股股东苏州市聚杰投资有限公司（以下 简称"聚杰投资"）因引进产业投资方（上海汽车集团金控管理有限公司） 及自身经营性资金需求，计划自本次减持计划预披露公告之日起15个交易日 后的3个月内以大宗交易方式减持本公司股份不超过2,984,100股（即减持比 例不超过公司当前总股本的2%）。 公司于2025年12月8日收到控股股东聚杰投资《关于股份减持计划完成 的告知函》，聚杰投资于2025年12月8日以大宗交易方式累计减持公司股份 2,984,100股，占公司总股本的2%。本次减持与此前披露的减持 ...

证券日报网讯 12月3日，聚杰微纤在互动平台回答投资者提问时表示，截至2025年11月28日，公司股东 人数为10107户。 （文章来源：证券日报） ...

Group 1 - The company is currently in the small-scale sample delivery phase for solid-state battery membranes and has not yet commenced mass production, resulting in no substantial sales to date [1]

Group 1 - The core viewpoint of the article is that 聚杰微纤 (Jujie Microfiber) is currently in the small-scale sample delivery phase for its solid-state battery membrane, with no mass production or substantial sales yet [1] Group 2 - The company is identified by its stock code 300819 and is listed on the Shenzhen Stock Exchange [1]

Group 1: Company Research and Development - The company has its own research center and collaborates extensively with external universities and research institutions [1] - Currently, the solid-state battery membrane is in the small-scale sample delivery phase, with no mass production or substantial sales yet [1] Group 2: Product Applications and Market Focus - The company's products are based on ultra-fine fiber technology, focusing on industrial fabric applications [1] - The company is optimistic about future growth, particularly in sportswear fabrics, automotive interior fabrics, and electronic product fabrics [2] Group 3: Product Development and Commercialization - Samples of bio-inspired muscle fibers are available, and the company is conducting applied research with leading robotics manufacturers, but no mass production or revenue has been generated yet [2] - The company has been testing hydrogen separation membrane samples since last year and aims to expedite the commercialization process [2] Group 4: Financial Strategy and Future Plans - The company will formulate future funding plans based on its needs, especially after a major shareholder transferred equity to an industry partner [2]

证券日报网讯聚杰微纤（300819）11月25日在互动平台回答投资者提问时表示，截至2025年11月20日， 公司股东户数为10341户。 ...

聚杰微纤11月25日披露，截至11月20日公司股东户数为10341户，较上期（11月10日）减少1043户，环 比降幅为9.16%。 （文章来源：证券时报网） 证券时报·数据宝统计，截至发稿，聚杰微纤最新股价为23.19元，上涨0.30%，本期筹码集中以来股价 累计下跌8.92%。具体到各交易日，5次上涨，6次下跌。 公司发布的三季报数据显示，前三季公司共实现营业收入4.48亿元，同比下降7.11%，实现净利润 5248.91万元，同比下降9.30%，基本每股收益为0.3500元，加权平均净资产收益率5.94%。（数据宝） ...

Group 1: China Construction - The total new contracts signed by China Construction from January to October reached 3.61 trillion yuan, representing a year-on-year increase of 1% [1] Group 2: Changyuan Power - Changyuan Power's subsidiary received approval for the 100MW wind power project in Songzi, Hubei [2] Group 3: China Metallurgical Group - China Metallurgical Group reported a total new contract amount of 845.07 billion yuan from January to October, a decrease of 11.8% year-on-year, while overseas contracts increased by 7.3% to 71.16 billion yuan [4] Group 4: Shapuaisi - Shapuaisi received approval for clinical trials of deoxycorticosterone ketone solution, intended for use during cataract surgery [5] Group 5: Jianfeng Group - Jianfeng Group's subsidiary received approval for clinical trials of a new drug for treating advanced non-squamous non-small cell lung cancer [7] Group 6: Chongqing Steel - Chongqing Steel announced the resignation of its president Meng Wenwang due to work adjustments [8] Group 7: Tianma Technology - Tianma Technology reported an output of approximately 1732.99 tons of eel in October, with a total output of about 15218.73 tons from January to October [10] Group 8: Qingyuan Co. - Qingyuan Co.'s controlling shareholder reduced holdings of convertible bonds by 685,400 units, accounting for 13.71% of the total issuance [11] Group 9: Spring Airlines - Spring Airlines reported a passenger turnover of 506,200.49 million kilometers in October, a year-on-year increase of 20.06% [12] Group 10: China Merchants Port - China Merchants Port reported a total container volume of 17.1714 million TEUs from January to October, a year-on-year increase of 5.1% [13] Group 11: Yangdian Technology - Yangdian Technology announced a change in control following a share transfer [15] Group 12: Wanfu Biology - Wanfu Biology decided to postpone the implementation of its Knowledge City production base project [16] Group 13: Iwu Biology - Iwu Biology terminated the research project for a specific drug, which will reduce its 2025 net profit by approximately 333.79 million yuan [17] Group 14: Hainan Rubber - Hainan Rubber received an insurance payout of 22.9241 million yuan due to revenue loss from rubber price fluctuations [19] Group 15: Xinjiang Tianye - Xinjiang Tianye plans to establish a joint venture with Tianchi Energy to develop coal chemical projects [20] Group 16: China Coal Energy - China Coal Energy's executive director and president Zhao Rongzhe resigned due to reaching retirement age [22] Group 17: Huading Co. - Huading Co. received approval for a stock issuance to specific investors from the Shanghai Stock Exchange [24] Group 18: Zhongmu Co. - Zhongmu Co. decided to waive its right of first refusal for a 4.04% stake in a subsidiary [25] Group 19: Tianlong Co. - Tianlong Co. reported that its subsidiary's stock issuance was approved by the Beijing Stock Exchange [26] Group 20: Hualan Co. - Hualan Co.'s subsidiary plans to invest 20 million yuan in a biotechnology company [27] Group 21: Haichen Pharmaceutical - Haichen Pharmaceutical received a drug registration certificate for a new injection [28] Group 22: Aier Eye Hospital - Aier Eye Hospital plans to invest 300 million yuan in wealth management products [29] Group 23: Xiamen Engineering Machinery - Xiamen Engineering Machinery announced a planned share reduction by a major shareholder [30] Group 24: Guotai Group - Guotai Group successfully acquired 100% of a mining technology company for 110.1 million yuan [31] Group 25: Wanfeng Aowei - Wanfeng Aowei reached a settlement regarding an arbitration matter with a subsidiary [32] Group 26: Taihe Technology - Taihe Technology is undergoing technical upgrades for its ethylene carbonate project [33] Group 27: Renhe Pharmaceutical - Renhe Pharmaceutical's controlling shareholder plans to reduce holdings by 0.21% [34] Group 28: Changshu Bank - Changshu Bank's second-largest shareholder increased its stake to 3.98% [35] Group 29: Overseas Chinese Town A - Overseas Chinese Town A reported a 57% decrease in contract sales in October [36] Group 30: Canadian Solar - Canadian Solar's controlling shareholder expects total revenue of 1.3 to 1.5 billion USD in Q4 2025 [38] Group 31: Zhonggong Education - Zhonggong Education's controlling shareholder's shares will be auctioned due to a loan dispute [40] Group 32: Aikexibo - Aikexibo's shareholders plan to reduce their holdings by up to 3% [42] Group 33: Wanhua Chemical - Wanhua Chemical's shareholder plans to reduce holdings by up to 0.5% [44] Group 34: Jujie Microfiber - Jujie Microfiber's controlling shareholder plans to reduce holdings by up to 2% [45] Group 35: Wangsu Technology - Wangsu Technology's shareholder plans to reduce holdings by up to 1% [46] Group 36: Tianli Lithium Energy - Tianli Lithium Energy received a patent for lithium-ion battery materials [47] Group 37: Heshun Electric - Heshun Electric won a 40 million yuan project for energy storage services [49] Group 38: Changchun High-tech - Changchun High-tech's subsidiary received FDA approval for a clinical trial of a new drug [51] Group 39: Dongrui Co. - Dongrui Co. received an additional export quota for live pigs to Hong Kong [52] Group 40: Zhongwei Co. - Zhongwei Co. set the H-share issuance price at 34 HKD per share [53] Group 41: Fospower Technology - Fospower Technology plans to invest in a lithium sulfide project with partners [54]